GLP-1 therapy may be ideal if you: Your program typically involves: Most patients begin noticing appetite reduction within the first 24 weeks
They usually subside within the first few days to two weeks of consistent ColonBroom use, so it's important to be patient and understanding during this adjustment period
Nov 24, 2024 Episode 17 - WebAIRS incidents relating to GLP-1 agonists Sharing insights from a recent webAIRS case study, Dr Clayton Lam joins the podcast for a krero on the impacts an increased use of glucagon-like peptide-1 (GLP-1) and off-label GLP-1 agonists is having on perioperative anaesthesia care, as reported to webAIRS
pJRD215, a wide-host-range cosmid vector with multiple cloning sites
SIRT1 deacetylase in aging-induced neuromuscular degeneration and amyotrophic lateral sclerosis
Zepbound is approved to treat obesity, and Mounjaro is approved for diabetes